Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome
About
Immune-mediated, non-communicable diseases, such as autoimmune diseases, allergic diseases and asthma, are chronic disorders in which the immune system plays a pivotal role. The World Health Organisation (WHO) has highlighted the seriousness of autoimmunity and its association with exposure to the environment.
EXIMIOUS aims to deliver a new way of assessing the human exposome, i.e. the exposures to environmental factors that one experiences throughout life, and shed light on its association to immune-mediated diseases.
Partners
EXIMIOUS is part of the European Human Exposome Network and brings together 15 partner organisations from 7 European countries.
FAQ
Don’t know what the exposome is?
Want to know more about exposure-related immune diseases?
Curious to know more about what to expect from this project?
Latest news
New publication: Data management and protection in occupational and environmental exposome research – A case study from the EU-funded EXIMIOUS project
We are happy to announce that our new publication on “Data management and protection in occupational and environmental exposome research – A case study from the EU-funded EXIMIOUS project” has been published by Environmental Research and is available to read online. Within collaborative projects, such as the EU-funded Horizon 2020 EXIMIOUS project (Mapping Exposure-Induced Immune
‘Risk assessment of mixed exposures’ – Take-aways from the 5th EXIMIOUS Symposium
Did you miss the fifth EXIMIOUS Symposium on 28 September 2023? Read our key take-aways and watch the full recording on the EXIMIOUS YouTube channel.
AI, environmental exposures and autoimmune diseases – EXIMIOUS’ opinion piece in the EHEN blog
EXIMIOUS’ opinion piece on artificial intelligence and how it can be used in data-driven exposome research.
Project facts
EXIMIOUS is a 5 year Research and Innovation Action funded by the European Union’s Horizon 2020 programme.
- Concept: introduce a new approach to mapping exposure-induced immune effects by combining exposomics and immunomics in a unique toolbox.
- Budget: 10.8 million Euro
- Duration: 01.01.2020 - 31.12.2024
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874707.
